William E. Delaney IV - 16 Feb 2023 Form 4 Insider Report for ASSEMBLY BIOSCIENCES, INC. (ASMB)

Role: Chief Scientific Officer
Signature: /s/ John O. Gunderson, as Attorney-in-Fact
Issuer symbol: ASMB
Transactions as of: 16 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 17 Feb 2023, 15:10:58 UTC
Previous filing: 03 Aug 2022
Next filing: 31 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ASMB	Common Stock	Award	$0	+10,000	+13%	$0.000000	88,919	16 Feb 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On February 16, 2023, a performance-based vesting condition was achieved with respect to these shares of common stock, which remain subject to time-based vesting and will vest in two equal installments, assuming continuous service on each vesting date, as follows: August 1, 2023 and August 1, 2024.
F2	Includes 2,500 shares acquired under the Assembly Biosciences, Inc. Amended and Restated 2018 Employee Stock Purchase Plan on November 14, 2022.

Content

Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On February 16, 2023, a performance-based vesting condition was achieved with respect to these shares of common stock, which remain subject to time-based vesting and will vest in two equal installments, assuming continuous service on each vesting date, as follows: August 1, 2023 and August 1, 2024.

Includes 2,500 shares acquired under the Assembly Biosciences, Inc. Amended and Restated 2018 Employee Stock Purchase Plan on November 14, 2022.